Clinical trial
A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative…
NCT00108095 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00108095 |
|---|---|
| Title | A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Oral Neurokinin-1 Receptor Antagonist, GW679769, When Administered With Intravenous Ondansetron Hydrochloride for the Prevention of… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative |
| Intervention type | Drug |
| Interventions | intravenous ondansetron |
| Enrollment | 701 |
| Start date | Oct 1, 2004 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Apr 14, 2005 |
| Last update posted | Jan 20, 2017 |
| Countries | Belgium, Canada, Germany, Hungary, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: